By Dania Shamil MPharmS, MSc, PV Manager of International Pharmacovigilance and UK QPPV at Vertex Pharmaceuticals
Having worked in various sectors of pharmacy including hospital, community and academia I found my passion in drug safety and the pharmaceutical industry. I wanted to improve my technical knowledge in drug safety, therefore I completed an MSc in Pharmacovigilance (PV) soon after my MPharm degree at the Drug Safety Research Unit (DSRU). I recognised that I had a great career ahead and my enthusiasm grew knowing that I could ensure patient safety by monitoring the adverse effects of marketed or investigational drugs. It is a great career for a pharmacist as you are still able to use the scientific knowledge gained in a MPharm degree, as well as develop new skills. drug safety it is a very important role in the drug lifecycle! With the increasing changes in drug safety regulations globally, I am continuously developing my technical PV knowledge as well as my analytical skills, which is the central theme in a PV career. No two days are the same!
I am the founder and leader of the ‘Thinking of a career in drug safety course’. It is a new and exciting course for anyone interested in a career in drug safety. Previous experience is not required. The course helps pharmacists understand the opportunities that the pharmaceutical industry presents.
The course is taught by leading experts who have extensive experience in drug safety and who will share their insights and provide advice for the array of career options. The course will introduce the importance of drug safety, how this affects patients and what it is like to work in a patient safety department. Practical workshops will give delegates an understanding of the ongoing and proactive drug safety activities which are taking place in the patient safety departments and the key partnerships with health authorities to ensure that the patients are safe whilst they are taking medicines.
Dania Shamil MPharmS, MSc, PV Manager of International Pharmacovigilance and UK QPPV at Vertex Pharmaceuticals.